PLX
Protalix Biotherapeutics Inc
2.80$
-1.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -71.2% | +110.8% | +129.1% | +62.4% | +59.7% | +15.0% | -39.0% | +24.2% | +37.5% | -18.5% | -1.2% | |
| – | -91.9% | +1,050.4% | +81.4% | -38.9% | +17.1% | -0.2% | +50.4% | +19.8% | +17.3% | +5.8% | +13.1% | |
| – | -40.5% | -78.0% | +630.0% | +326.5% | +75.6% | +18.8% | -57.7% | +27.5% | +51.6% | -31.6% | -13.2% | |
| – | -26.8% | +51.9% | -5.2% | +15.6% | +33.9% | -14.5% | -22.1% | -1.3% | -41.8% | -24.1% | +46.9% | |
| – | -24.7% | +28.5% | +23.2% | -83.2% | +207.9% | -14.7% | -21.0% | +237.8% | +87.5% | +60.2% | -71.4% | |
| – | -12.8% | +24.4% | +18.8% | +9.6% | +23.2% | -9.5% | -13.9% | -3.3% | -21.9% | -21.5% | +22.1% | |
| – | – | – | – | – | – | – | -855.1% | – | – | -62.6% | -240.4% | |
| – | -24.3% | +12.2% | +132.0% | -21.0% | +3.7% | +21.4% | -22.2% | -66.4% | +25.7% | -66.6% | +12.1% | |
| – | – | – | – | – | – | – | – | – | – | -51.5% | -235.0% | |
| – | – | – | -28.1% | -93.1% | +1,386.2% | +5.1% | -23.5% | -91.7% | -52.1% | +381.1% | -18.5% | |
| – | – | -150.6% | – | – | – | – | – | – | – | -64.7% | -325.2% | |
| – | – | – | – | – | – | – | -525.7% | – | – | -49.6% | -145.3% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.